Erlotinib Hydrochloride Sandoz

Erlotinib Hydrochloride Sandoz is an oral medication used to treat certain types of cancer. This medication is designed to target specific proteins involved in cancer cell growth.

Erlotinib Hydrochloride Sandoz is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the growth and spread of cancer cells. This medication is often prescribed for patients who have specific genetic markers that make them suitable candidates for this type of treatment.

Common effects of Erlotinib Hydrochloride Sandoz may include skin rash, diarrhea, and fatigue. Some users may also experience loss of appetite, nausea, and dry skin. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Hydrochloride Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking.

Erlotinib Hydrochloride Sandoz may interact with certain medications, including those that are metabolized by the liver. It is important to avoid taking this medication with other drugs that can cause similar side effects, such as severe diarrhea or skin reactions. Always consult your healthcare provider before starting any new medication while taking Erlotinib Hydrochloride Sandoz.